Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 2
  • >
  • Combined treatment with sertindole and clozapine for patients with drug-resistant schizophrenia. 4 cases reports

Archive 1995–2023

2012, volume 28, issue 2
Case report

Combined treatment with sertindole and clozapine for patients with drug-resistant schizophrenia. 4 cases reports

Farmakoterapia w Psychiatrii i Neurologii, 2012, 2, 87–93
Keywords: treatment-resistant schizophrenia, clozapine, sertindole
Summary

We report four cases (2 men and 2 women) of schizophrenia patients resistant to pharmacological treatment, in whom all neuroleptics available in Poland were used without satisfactory effect. Patients were treated in the Department of Psychiatry of Medical University of Lublin between 2008 and 2011. The applied combined therapy consisted of sertindole, 16–20 mg/d and clozapine, 100–600 mg/d. A signifi cant improvement of the mental state was achieved during the first two months of gradually introduced treatment. In all patients, a signifi cant reduction of positive and deficit symptom occurred as well as improvement in functioning. Monitoring of the heart did not reveal prolongation of the QT segment or the QTc, and no arrhythmias were observed. The results obtained show that combined treatment with sertindole and clozapine was found to be effective and safe for patients with drug-resistant schizophrenia.

Correspondence address
Bożena Śpila
Katedra i Klinika Psychiatrii UM
ul. Głuska 1, 20-349 Lublin
tel.: 81 74 409 67
e-mail: [email]bozena.spila@umlub.pl[/email]
You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links